LenioBio, a leader in rapid cell-free protein expression technologies, has partnered with ReciBioPharm, a global contract development and manufacturing organization (CDMO), to scale up protein manufacturing capabilities and expedite vaccine production.   This collaboration is part of the expansion in scope of LenioBio’s CEPI-funded project, which aims to showcase the capacity and speed of LenioBio’s proprietary ALiCE protein expression technology to accelerate production of vaccine...